Neurodegenerations with Brain Iron Accumulation

Parkinsonism and Related Disorders

Volumn 22, Issue , 2016, Pages S21-S25

  Schneider, Susanne A ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Basal ganglia; Dystonia; Hallervorden Spatz; Iron accumulation; Pallidum; PKAN

Indexed keywords

CERULOPLASMIN; IRON;

ACERULOPLASMINEMIA; ARTICLE; BRAIN ATROPHY; BRAIN DISEASE; CERULOPLASMIN GENE; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FTL1 GENE; GENE; GENE MUTATION; GENETIC SCREENING; HUMAN; IRON STORAGE; MOLECULAR DIAGNOSIS; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROFERRITINOPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ANIMAL; BRAIN; GENETIC VARIATION; GENETICS; METABOLISM; NEURODEGENERATIVE DISEASES;

ANIMALS; BRAIN; GENETIC VARIATION; HUMANS; IRON; NEURODEGENERATIVE DISEASES;

EID: 84947868006     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.08.012     Document Type: Article

References (29)

1. Hayflick S.J. Neurodegeneration with brain iron accumulation: from genes to pathogenesis. Semin. Pediatr. Neurol. 2006, 13:182-185.
2. Hayflick S.J., Westaway S.K., Levinson B., Zhou B., Johnson M.A., Ching K.H., Gitschier J. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. New Engl. J. Med. 2003, 348:33-40.
3. Gregory A., Polster B.J., Hayflick S.J. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J. Med. Gen. 2009, 46:73-80.
4. Hartig M.B., Hortnagel K., Garavaglia B., Zorzi G., Kmiec T., Klopstock T., Rostasy K., Svetel M., Kostic V.S., Schuelke M., Botz E., Weindl A., Novakovic I., Nardocci N., Prokisch H., Meitinger T. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann. Neurol. 2006, 59:248-256.
5. Dusi S., Valletta L., Haack T.B., Tsuchiya Y., Venco P., Pasqualato S., Goffrini P., Tigano M., Demchenko N., Wieland T., Schwarzmayr T., Strom T.M., Invernizzi F., Garavaglia B., Gregory A., Sanford L., Hamada J., Bettencourt C., Houlden H., Chiapparini L., Zorzi G., Kurian M.A., Nardocci N., Prokisch H., Hayflick S., Gout I., Tiranti V. Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. Am. J. Hum. Gen. 2014, 94:11-22.
6. Paisan-Ruiz C., Bhatia K.P., Li A., Hernandez D., Davis M., Wood N.W., Hardy J., Houlden H., Singleton A., Schneider S.A. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann. Neurol. 2009, 65:19-23.
7. Hartig M., Prokisch H., Meitinger T., Klopstock T. Mitochondrial membrane protein-associated neurodegeneration (MPAN). Int. Rev. Neurobiol. 2013, 110:73-84.
8. Haack T.B., Hogarth P., Gregory A., Prokisch H., Hayflick S.J. BPAN: the only X-linked dominant NBIA disorder. Int. Rev. Neurobiol. 2013, 110:85-90.
9. Nishioka K., Oyama G., Yoshino H., Li Y., Matsushima T., Takeuchi C., Mochizuki Y., Mori-Yoshimura M., Murata M., Yamasita C., Nakamura N., Konishi Y., Ohi K., Ichikawa K., Terada T., Obi T., Funayama M., Saiki S., Hattori N. High frequency of beta-propeller protein-associated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism. Neurobiol. Aging 2015, 36:2004.e9-2004.e15.
10. Kruer M.C., Paisan-Ruiz C., Boddaert N., Yoon M.Y., Hama H., Gregory A., Malandrini A., Woltjer R.L., Munnich A., Gobin S., Polster B.J., Palmeri S., Edvardson S., Hardy J., Houlden H., Hayflick S.J. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann. Neurol. 2010, 68:611-618.
11. Paisan-Ruiz C., Guevara R., Federoff M., Hanagasi H., Sina F., Elahi E., Schneider S.A., Schwingenschuh P., Bajaj N., Emre M., Singleton A.B., Hardy J., Bhatia K.P., Brandner S., Lees A.J., Houlden H. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov. Disord. 2010, 25:1791-1800.
12. Chinnery P.F., Crompton D.E., Birchall D., Jackson M.J., Coulthard A., Lombes A., Quinn N., Wills A., Fletcher N., Mottershead J.P., Cooper P., Kellett M., Bates D., Burn J. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 2007, 130:110-119.
13. Chinnery P.F., Curtis A.R., Fey C., Coulthard A., Crompton D., Curtis A., Lombes A., Burn J. Neuroferritinopathy in a French family with late onset dominant dystonia. J. Med. Gen. 2003, 40:e69.
14. Vroegindeweij L.H., van der Beek E.H., Boon A.J., Hoogendoorn M., Kievit J.A., Wilson J.H., Langendonk J.G. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series. Diabet. Med. 2015, 32:993-1000.
15. Amaral L.L., Gaddikeri S., Chapman P.R., Roy R., Gaddikeri R.S., Marussi V.H., Bag A.K. Neurodegeneration with brain iron accumulation: clinicoradiological approach to diagnosis. J. Neuroimag. 2015, 25:539-551.
16. Delgado R.F., Sanchez P.R., Speckter H., Then E.P., Jimenez R., Oviedo J., Dellani P.R., Foerster B., Stoeter P. Missense PANK2 mutation without "eye of the tiger" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN). J. Magn. Reson. imaging JMRI 2012, 35:788-794.
17. Kurian M.A., Morgan N.V., MacPherson L., Foster K., Peake D., Gupta R., Philip S.G., Hendriksz C., Morton J.E., Kingston H.M., Rosser E.M., Wassmer E., Gissen P., Maher E.R. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 2008, 70:1623-1629.
18. Paisan-Ruiz C., Li A., Schneider S.A., Holton J.L., Johnson R., Kidd D., Chataway J., Bhatia K.P., Lees A.J., Hardy J., Revesz T., Houlden H. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol. Aging 2012, 33:814-823.
19. Paisan-Ruiz C., Bhatia K.P., Li A., Hernandez D., Davis M., Wood N.W., Hardy J., Houlden H., Singleton A., Schneider S.A. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann. Neurol. 2009, 65:19-23.
20. Hogarth P., Gregory A., Kruer M.C., Sanford L., Wagoner W., Natowicz M.R., Egel R.T., Subramony S.H., Goldman J.G., Berry-Kravis E., Foulds N.C., Hammans S.R., Desguerre I., Rodriguez D., Wilson C., Diedrich A., Green S., Tran H., Reese L., Woltjer R.L., Hayflick S.J. New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology 2013, 80:268-275.
21. Hayflick S.J., Kruer M.C., Gregory A., Haack T.B., Kurian M.A., Houlden H.H., Anderson J., Boddaert N., Sanford L., Harik S.I., Dandu V.H., Nardocci N., Zorzi G., Dunaway T., Tarnopolsky M., Skinner S., Holden K.R., Frucht S., Hanspal E., Schrander-Stumpel C., Mignot C., Heron D., Saunders D.E., Kaminska M., Lin J.P., Lascelles K., Cuno S.M., Meyer E., Garavaglia B., Bhatia K., de Silva R., Crisp S., Lunt P., Carey M., Hardy J., Meitinger T., Prokisch H., Hogarth P. beta-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain 2013, 136:1708-1717.
22. Ohta E., Takiyama Y. MRI findings in neuroferritinopathy. Neurol. Res. Int. 2012, 2012:197438.
23. Batla A., Adams M.E., Erro R., Ganos C., Balint B., Mencacci N.E., Bhatia K.P. Cortical pencil lining in neuroferritinopathy: a diagnostic clue. Neurology 2015, 84:1816-1818.
24. McNeill A., Birchall D., Hayflick S.J., Gregory A., Schenk J.F., Zimmerman E.A., Shang H., Miyajima H., Chinnery P.F. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008, 70:1614-1619.
25. Schneider S.A., Dusek P., Hardy J., Westenberger A., Jankovic J., Bhatia K.P. Genetics and pathophysiology of neurodegeneration with brain iron accumulation (NBIA). Curr. Neuropharm. 2013, 11:59-79.
26. Kalman B., Lautenschlaeger R., Kohlmayer F., Buchner B., Kmiec T., Klopstock T., Kuhn K.A. An international registry for neurodegeneration with brain iron accumulation. Orphanet J. Rare Dis. 2012, 7:66.
27. Yonekawa M., Okabe T., Asamoto Y., Ohta M. A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh frozen plasma. Eur. Neurol. 1999, 42:157-162.
28. McNeill A., Birchall D., Hayflick S.J., Gregory A., Schenk J.F., Zimmermann E.A., Shang H., Miyajima H., Chinnery P.F. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008, 70:1614-1619.
29. Kuhn J., Bewermeyer H., Miyajima H., Takahashi Y., Kuhn K.F., Hoogenraad T.U. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate. Brain Dev. 2007, 29:450-453.